WuXi Reports Expanded Research Deal With J&J And Higher Profits, But Also Sharper Risks Sparked By Global Financial Crisis

BEIJING - WuXi PharmaTech reported strong earnings growth for the third quarter, but also cautioned that the financial crisis sweeping across the globe would cut into profits for the whole of 2008